Home > Our Researchers > John A. Boockvar, MD
John A. Boockvar, MD
Investigator, Laboratory for Brain Tumor Biology and Therapy, The Feinstein Institute for Medical Research
Director, Brain Tumor Center, Lenox Hill Hospital
Director, Center for Pituitary Surgery & Acoustic Neuroma Program, New York Head and Neck Institute
Professor of Neurosurgery, Hofstra North Shore-LIJ School of Medicine
Phone: (212) 434-3900
Dr. John Boockvar is director of the Brain Tumor Center, Pituitary/Neuroendocrine Center and the Acoustic Neuroma Program of the Division of Neurological Surgery and the New York Head and Neck Institute at Lenox Hill and Manhattan Eye, Ear and Throat Hospitals.
Dr. Boockvar is an investigator in the Laboratory of Brain Tumor Biology and Therapy in the Center of Cell Biology, Oncology and Neuroscience at the Feinstein Institute for Medical Research.
Dr. Boockvar also directs the Brain Tumor Biotech Center at the Institute.
Dr. Boockvar is a professor of Neurological Surgery at the Hofstra North Shore-LIJ School of Medicine.
is internationally known for his
surgical expertise and for providing patients with safe, effective, and minimally invasive treatment for brain tumors, skull base disorders, and disorders of the spine.
surgical expertise is in benign and malignant brain tumors, skull base and endoscopic pituitary surgery, spinal and peripheral nerve tumors, minimally invasive spinal surgery, and complex spinal disorders.
has been recognized for his
novel research in brain tumors and stem cell biology.
has been named to the lists of New York's Top Docs, Best Doctors in New York, America's Top Surgeons, America's Best Doctors, and America's Best Doctors for Cancer.
His research has been widely published and he has received numerous national awards including the Eric Lichtenstein Humanitarian Award from Voices Against Brain Cancer for his compassionate work in treating patients with brain cancer.
has been repeatedly featured on CNN
, ABC, CNBC, CBS
, and Fox News Channel, and has appeared on The Dr. Oz Show as well as in the New York Times
, New York Daily News
, and Crain's
Business Journal among others.
In 2007, Dr. Boockvar
received acclaim for helping to save a window washer who had fallen 47 stories.
By operating on both his
brain and spinal cord, Dr. Boockvar
not only saved the man's life but helped him to walk again and regain normal functioning (see The New York Times article about the surgery, as well as a 2014 update on the patient in the New York Post).
has been on the cover of The New York Times Science Times
On November 9, 2010, the anniversary issue of the Science Times
asked science reporters and top researchers to provide their watch list for noteworthy advances in 2011 and to identify which "fields are hot.
This list included Dr. Boockvar
and the studies he
is conducting for people with Glioblastoma Multiforme (see article).
currently co-directs the Laboratory for Brain Tumor Biology and Therapy at the Feinstein Institute for Medical Research
laboratory interests have focused on adult human neural stem cell biology as it relates to brain tumor formation and resistance to therapy.
Dr. Boockvar is a world expert on blood brain barrier disruption to improve the delivery of therapeutics to the human brain.
Dr. Boockvar is the principal investigator of several cutting edge clinical trials using blood brain barrier disruption to deliver high dose chemotherapy for patients with malignant brain tumors that have been featured in the New York Times and Wall Street Journal.
Dr. Boockvar has served as Editor-in-Chief of the journal Current Stem Cell Research and Therapy and is an editorial board member of the Journal of Neuro-Oncology, Neurosurgery, Journal of Neurosurgery, and Recent Patents on Anti-Cancer Drug Discovery.
Dr. Boockvar directs the Brain Tumor Biotech Center at the Institute that seeks to bridge the translational gap between basic and clinical science for patients with malignant brain tumors.
Dr. Boockvar's laboratory has been funded by the National Institutes of Health and he was recently awarded the American Association of Neurological Surgeons Pinnacle Partners Award for his research into brain tumors.
has also won research awards from Voices Against Brain Cancer, the American Brain Tumor Association, the Starr Foundation, Anspach Companies, and the Adelson Foundation